Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Immunologic manifestations of autophagy
Vojo Deretic, … , Santosh Chauhan, Michael Mandell
Vojo Deretic, … , Santosh Chauhan, Michael Mandell
Published January 2, 2015
Citation Information: J Clin Invest. 2015;125(1):75-84. https://doi.org/10.1172/JCI73945.
View: Text | PDF
Review

Immunologic manifestations of autophagy

  • Text
  • PDF
Abstract

The broad immunologic roles of autophagy span innate and adaptive immunity and are often manifested in inflammatory diseases. The immune effects of autophagy partially overlap with its roles in metabolism and cytoplasmic quality control but typically expand further afield to encompass unique immunologic adaptations. One of the best-appreciated manifestations of autophagy is protection against microbial invasion, but this is by no means limited to direct elimination of intracellular pathogens and includes a stratified array of nearly all principal immunologic processes. This Review summarizes the broad immunologic roles of autophagy. Furthermore, it uses the autophagic control of Mycobacterium tuberculosis as a paradigm to illustrate the breadth and complexity of the immune effects of autophagy.

Authors

Vojo Deretic, Tomonori Kimura, Graham Timmins, Pope Moseley, Santosh Chauhan, Michael Mandell

×

Figure 3

A spectrum of autophagic processes governs elimination of intracellular microbes.

Options: View larger image (or click on image) Download as PowerPoint
A spectrum of autophagic processes governs elimination of intracellular ...
Extracellular bacteria (pink) can induce autophagy by stimulating TLRs (i) or NODs (ii) upon shedding of PAMPs or during phagocytosis (iii). The latter induces a hybrid process termed LAP. Intracellular bacteria can be eliminated through canonical autophagy sponsored by SLRs. Some SLRs can recognize galectins (Gal) bound to β-galactoside glycans on pathogen-associated damaged vacuolar membranes (iv), whereas all SLRs identified thus far recognize ubiquitin (Ubq) on cytosolic bacteria or associated host molecules (v). A viral core can be recognized by TRIMs, which act as receptors and inducers of autophagy, thus helping to eliminate retroviral material en route to the nucleus (vi). Fusion with lysosomes leads to formation of autolysosomes (from canonical autophagy acting on cytosolic targets) or autophagolysosomes (from LAP phagosomes or from damaged conventional phagosomes). Elimination of many pathogens involves not one but a spectrum of autophagic processes (processes i–vi correspond to the above descriptions): AP, autophagy; X1, xenophagy mixed with autophagy of host membranes; X2, xenophagy of microbes only; HSX, highly selective xenophagy.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts